Peterson Tycho
- SEC CIK
- 0001927856
No open-market purchases or sales filed in the past year.
Current role at each company
- ADPT Adaptive Biotechnologies CorpChief Financial Officeras of Mar 6, 2024
- SLGC SomaLogic, Inc.Directoras of Jan 9, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Peterson Tycho as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ADPT Adaptive Biotechnologies Corp
Chief Financial Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 (view filing) | Mar 5 | 1 day | Peterson TychoChief Financial Officer | SSale | −15.5K | $3.44 | −$53.2K | −2.8%531.6K after | |
| Jun 21, 2023 (view filing) | Jun 20 | 1 day | Peterson TychoChief Financial Officer | SSale | −135.0K | $8.14 | −$1.10M | −25.3%399.2K after | 2 lots10b5-1 |
| Jun 20, 2023 (view filing) | Jun 15 | 5 days | Peterson TychoChief Financial Officer | SSale | −70.0K | $8.53 | −$597.1K | −14.9%399.2K after | 2 lots10b5-1 |
| Jun 6, 2023 (view filing) | Jun 2 | 4 days | Peterson TychoChief Financial Officer | SSale | −38.0K | $7.16 | −$272.1K | −7.7%454.9K after |